Recently COVID19 was also associated with an ADAM17 malfunction, which further underlines the current importance of understanding the inhibition mechanism of ADAM17 in detail for external regulation through substrate-specific inhibitors [56,57,58,59,60]. This evidence concerns the gene ADAM17 and COVID-19.